Our Pricing

Wegovy Weight Loss Injection: UK Online Pharmacy Guide

Published on: June 03, 2026

When you buy Wegovy online UK from £79.00 at Cured Pharmacy, you're accessing genuine UK-licensed semaglutide injections with full prescriber support and transparent pricing. Our GPhC-registered pharmacy delivers Wegovy pens discreetly across the UK, with free online consultations completed in under three minutes by our clinical team led by superintendent pharmacist Tarun Kumar (GPhC 2233073).

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities [1]. Semaglutide mimics a natural gut hormone that regulates appetite and food intake by acting on receptors in the brain that control hunger signals.

In the landmark STEP 1 clinical trial, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represents one of the most significant weight loss outcomes observed in pharmaceutical trials for obesity treatment. Wegovy works by slowing gastric emptying, reducing appetite, and increasing feelings of fullness after meals, helping patients adhere to reduced-calorie diets more effectively [2].

Wegovy Dosing Schedule and What to Expect

Wegovy follows a gradual dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes [3]. Treatment begins with a 0.25mg weekly injection for the first four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg doses, reaching the maintenance dose of 2.4mg weekly by week 17.

This stepped approach allows your body to adjust to semaglutide's effects on gastric emptying and appetite regulation. Most patients report noticeable appetite reduction within the first two weeks, with progressive weight loss becoming evident from week four onwards [3]. Your UK prescriber will monitor your progress and may adjust the escalation schedule based on your tolerance and clinical response.

Administering Your Wegovy Pen

Wegovy arrives as a pre-filled, single-use pen that you inject subcutaneously once weekly into your abdomen, thigh, or upper arm. Each pen contains one dose and requires no preparation or mixing. Our clinical team provides detailed injection guidance during your consultation, and you'll receive printed instructions with your first prescription. Most patients find the injection process straightforward and report minimal discomfort at the injection site.

Who Can Use Wegovy: Eligibility Criteria

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. NICE guidelines support the use of GLP-1 receptor agonists like Wegovy as part of a comprehensive weight management programme that includes dietary modification and increased physical activity.

During your free online consultation at Cured Pharmacy, our UK prescribers will assess your medical history, current medications, and weight management goals to determine if Wegovy is clinically appropriate for you. Certain conditions preclude Wegovy use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy [4]. Your prescriber will discuss alternative treatments if Wegovy isn't suitable for your circumstances.

Common Side Effects and How to Manage Them

The most frequently reported side effects with Wegovy are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These effects typically emerge during dose escalation and often diminish as your body adjusts to the medication. In clinical trials, nausea affected approximately 44% of participants but was usually mild to moderate in severity and transient.

To minimise gastrointestinal symptoms, eat smaller, more frequent meals rather than large portions, avoid high-fat foods that delay gastric emptying further, and stay well-hydrated throughout the day. If nausea persists, your prescriber may recommend temporarily maintaining your current dose before escalating further. Serious but rare side effects include pancreatitis, gallbladder disease, and acute kidney injury secondary to severe dehydration from vomiting or diarrhoea [4]. Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, or signs of dehydration.

When to Seek Medical Advice

Whilst most side effects resolve without intervention, seek urgent medical attention if you develop symptoms of pancreatitis (severe upper abdominal pain radiating to the back, persistent vomiting), signs of thyroid tumours (lump in the neck, difficulty swallowing, persistent hoarseness), or symptoms of severe allergic reaction. Our clinical team at Cured Pharmacy remains available throughout your treatment to address concerns and adjust your prescription as needed.

Buy Wegovy Online UK: The Cured Pharmacy Process

Purchasing Wegovy through Cured Pharmacy combines clinical rigour with convenience. Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, and weight management objectives. Our UK-registered prescribers review your assessment within hours, not days, and issue a prescription if clinically appropriate.

Once approved, your Wegovy prescription is dispensed from our GPhC-registered pharmacy (registration number 9012511) and dispatched in discreet, temperature-controlled packaging. We guarantee the lowest prices in the UK whilst maintaining full regulatory compliance. Unlike some online services that show pricing only after consultation, we display transparent costs upfront so you can make informed decisions before starting the assessment process. All Wegovy supplied by Cured Pharmacy is UK-licensed and sourced through authorised pharmaceutical distributors, ensuring authenticity and proper cold-chain handling.

Wegovy vs Alternative Weight Loss Treatments

Several prescription weight loss treatments are available through UK pharmacies, each with distinct mechanisms, efficacy profiles, and dosing schedules. Wegovy's semaglutide acts exclusively on GLP-1 receptors, whilst newer dual-agonist medications target both GLP-1 and GIP pathways, potentially offering enhanced weight loss in some patients [5]. Older GLP-1 treatments require daily injections rather than Wegovy's convenient once-weekly schedule.

Oral weight loss medications work through different mechanisms entirely—some reduce fat absorption from the diet, whilst others affect neurotransmitters involved in appetite regulation. Injectable GLP-1 treatments like Wegovy generally demonstrate superior weight loss outcomes in clinical trials compared to oral alternatives, though individual responses vary [5]. Your UK prescriber will recommend the most appropriate treatment based on your medical history, lifestyle preferences, and previous weight management attempts.

Choosing Between Injectable Options

When comparing injectable weight loss treatments, consider dosing frequency, clinical trial outcomes, side effect profiles, and cost. Wegovy's once-weekly injection schedule offers convenience compared to daily alternatives, and its extensive clinical trial programme provides robust efficacy and safety data. Your prescriber will help you weigh these factors against your individual circumstances to identify the optimal treatment pathway.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2022). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. UK Public Assessment Report. [accessed 13 August 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and individual results may vary. Weight loss outcomes depend on adherence to treatment and lifestyle modifications.